UTI Healthcare Fund vs HDFC Pharma and Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1896 Cr | ₹1097 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 04 Oct 2023 | 30 Jul 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | BSE Healthcare |
| Turn Over | % | 28% |
| Expense Ratio | 2.14 | 2.22 |
| Manager | Dhruv Muchhal | Kamal Gada |
| ISIN Code | INF179KC1HL7 | INF789F01695 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | 2.06% | 1.24% |
| 6 Month | 7.93% | 7.65% |
| 1 Year | 6.22% | 2% |
| 3 Year | - | 23.73% |
| 5 Year | - | 17.94% |
SIP Return Analysis
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | 0.61% | 0.56% |
| 1 Year | 7.49% | 6.7% |
| 3 Year | - | 21.77% |
| 5 Year | - | 18.5% |
Rolling Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 27.59% | 11.94% |
| 3 Year | - | 16.4% |
| 5 Year | - | 14.62% |
Risk Management
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | - | 15.78% |
| Sharp | - | 1.03% |
| Beta | - | 0.95% |
| Alpha | - | 1.30% |
Fund Managers
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Dhruv Muchhal | Kamal Gada |
| Total AUM | ₹520687 Cr | ₹870 Cr |
| Funds Managed | 40 | 1 |
| HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 7.7 | 4.01 |
| Mid Cap | 30.89 | 33.54 |
| Small Cap | 35.06 | 40.04 |
| Large Cap | 26.35 | 22.4 |
Sector Allocation
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 1.03 | 1.02 |
| Basic Materials | 2.31 | 1.07 |
| Healthcare | 96.66 | 97.9 |
Top Comparisons
DSP Multi Asset Allocation Fund - Regular (G)
3Y Returns0%
Mirae Asset Multi Asset Allocation Fund-Reg (G)
3Y Returns0%
Invesco India Midcap Fund - Growth Option
3Y Returns27.26%
Sundaram Mid Cap Fund Regular Plan - Growth
3Y Returns24.2%
Aditya Birla Sun Life Infrastructure Fund-Growth
3Y Returns23.7%
Canara Robeco Infrastructure Fund - Regular Plan - Growth Option
3Y Returns25.61%
SBI Banking & PSU Fund - Regular Paln - Growth
3Y Returns7.47%
Sundaram Banking and PSU Fund - Regular Plan - Growth
3Y Returns7.65%